People · Operator
Named in public records as an officer, director or promoter · active 2012–2014 · Biotechnology, Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Fibrocell Science, Inc. | — | Biotechnology | Series C | $108.6M | $36.9M | 2012 |
| Total Defense, Inc. | — | Other Technology | Series A | $16.5M | $124.8M | 2012 |
| Mobisante, Inc. | — | Other Health Care | Series A | $4.2M | $84.6M | 2013 |
| Advanced Tear Diagnostics, LLC | — | Biotechnology | Seed | $1.8M | $62.9M | 2012 |
Marcus Smith at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Marcus Smith on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Barry Goldsmith | 1 | 6 |
| DOUGLAS J. SWIRSKY | 1 | 5 |
| KEITH A. GOLDAN | 1 | 3 |
| MICHAEL F. MARINO | 1 | 3 |
| Julian P. Kirk | 1 | 2 |
| James Socas | 1 | 2 |
| Julian Kirk | 1 | 2 |
| Catalina Valencia | 1 | 1 |
| Gene Wahnefried | 1 | 1 |
| Robert Langor | 1 | 1 |
| David Pernock | 1 | 1 |
| Paul Hopper | 1 | 1 |
| Kelvin Moore | 1 | 1 |
| Declan Daly | 1 | 1 |
| Marc Mazur | 1 | 1 |
| George Korkos | 1 | 1 |
| George J. Korkos | 1 | 1 |
| Kelvin J. Moore | 1 | 1 |
| JULIAN F. KIRK | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.